Regulations.gov document
Attachment 1 - Current (August 03, 2021) Orange Book Listing of PEPCID® (famotidine)…
Supporting & Related Material · FDA-2021-P-0885 · posted Aug 12, 2021
Key facts
| Document ID | FDA-2021-P-0885-0003 |
|---|---|
| Title | Attachment 1 - Current (August 03, 2021) Orange Book Listing of PEPCID® (famotidine) Tablets, 20 mg and 40 mg, NDA # N019462, Held by VALEANT PHARMACEUTICALS NORTH AMERICA LLC RE Citizen Petition from Zydus Pharmaceuticals (USA) Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-P-0885 |
| Posted | Aug 12, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: